# Biotech Daily Digest — 2025-10-27

**47 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 1 item
- Endpoints News: 5 items
- Fierce Biotech: 8 items
- MHRA – News: 1 item
- arXiv q-bio: 32 items


## Eli Lilly Press Releases

- **[Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis](https://investor.lilly.com/news-releases/news-release-details/lillys-omvoh-mirikizumab-mrkz-demonstrated-early-and-sustained)**  
  _Mon, 27 Oct 2025 06:45:00 -0400_  
  Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures — severity, frequency and stool deferral time — reflecting the spectrum of its burden on patients By Week 12, patients experienced a 55% reduction in daily episodes of bowel urgency


## Endpoints News

- **[WuXi AppTec to divest clinical services to focus on manufacturing business](https://endpoints.news/wuxi-apptec-to-divest-clinical-services-to-focus-on-manufacturing-business/)**  
  _Mon, 27 Oct 2025 13:42:32 +0000_  
  As WuXi AppTec’s manufacturing revenue recovers, it said it is selling its clinical research services business to a Hong Kong private equity firm.

 WuXi AppTec announced on Monday that its contract ...

- **[BridgeBio shifts filing plans for rare disease drug after Phase 3 success](https://endpoints.news/bridgebio-shifts-filing-plans-for-rare-disease-drug-after-phase-3-success/)**  
  _Mon, 27 Oct 2025 11:00:42 +0000_  
  BridgeBio on Monday trumpeted positive results from a Phase 3 rare disease study, potentially setting the company up with a stronger FDA pitch than it had originally thought.

 In the study’s interim analysis, BridgeBio’s drug ...

- **[Neumora moves forward with NLRP3 in obesity after Ventyx's drug failed to deliver weight loss](https://endpoints.news/neumora-moves-forward-with-nlrp3-in-obesity-after-ventyxs-drug-failed-to-deliver-weight-loss/)**  
  _Mon, 27 Oct 2025 10:30:05 +0000_  
  The "Really Big Neuroscience Company" is now also an obesity drug developer.

 Neumora is entering the pharma industry's most lucrative sector by advancing an NLRP3 inhibitor days after a competitor said its drug with the ...

- **[Novo ended Akero deal talks before returning for $4.7B MASH acquisition](https://endpoints.news/novo-ended-akero-deal-talks-before-returning-for-4-7b-mash-acquisition/)**  
  _Mon, 27 Oct 2025 07:40:11 +0000_  
  Novo Nordisk and a separate prospective buyer walked away from a potential acquisition of MASH drug developer Akero Therapeutics, before Novo came back to the table to finish the deal a few months later.  ...

- **[Novartis to buy RNA drugmaker Avidity Biosciences for $12B](https://endpoints.news/novartis-to-buy-rna-drugmaker-avidity-biosciences-for-12b/)**  
  _Sun, 26 Oct 2025 17:46:26 +0000_  
  Novartis plans to pay about $12 billion to acquire Avidity Biosciences, a neuromuscular drug developer that is months away from asking the FDA to approve its lead treatment candidate.

 The Sunday ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/intellia-pauses-phase-3-crispr-trials-after-patient-hospitalized" hreflang="en">Intellia pauses phase 3 CRISPR trials after patient is hospitalized</a>](https://www.fiercebiotech.com/biotech/intellia-pauses-phase-3-crispr-trials-after-patient-hospitalized)**  
  _Oct 27, 2025 9:20am_  
  Intellia Therapeutics has temporarily paused dosing and screening in a pair of phase 3 trials in response to a liver safety signal. Shares in Intellia fell 45% to $14.01 in premarket trading.

- **[<a href="https://www.fiercebiotech.com/biotech/zenas-lead-autoimmune-drug-sees-95-lesion-reduction-phase-2-ms-study" hreflang="en">Zenas' lead autoimmune drug prompts 95% reduction in new brain lesions in phase 2 MS study</a>](https://www.fiercebiotech.com/biotech/zenas-lead-autoimmune-drug-sees-95-lesion-reduction-phase-2-ms-study)**  
  _Oct 27, 2025 8:32am_  
  Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis study.

- **[<a href="https://www.fiercebiotech.com/sponsored/first-fda-ind-milestone-achieved-using-human-vascularized-organoid-efficacy-data" hreflang="en">First FDA IND Milestone Achieved Using Human Vascularized Organoid Efficacy Data</a>](https://www.fiercebiotech.com/sponsored/first-fda-ind-milestone-achieved-using-human-vascularized-organoid-efficacy-data)**  
  _Oct 22, 2025 1:07pm_  
  FDA approves IND based on human vascularized organoid efficacy data, marking a milestone in replacing animal POC testing.

- **[<a href="https://www.fiercebiotech.com/sponsored/de-risking-clinical-development-strategic-multipliers-global-trials" hreflang="en">De-Risking Clinical Development: Strategic Multipliers in Global Trials</a>](https://www.fiercebiotech.com/sponsored/de-risking-clinical-development-strategic-multipliers-global-trials)**  
  _Oct 23, 2025 12:30pm_  
  Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and expectations from regulators, payers, and patients continue to rise.

- **[<a href="https://www.fiercebiotech.com/biotech/bridgebio-aces-phase-3-rare-disease-test-clearing-path-fda" hreflang="en">BridgeBio aces phase 3 rare disease test, clearing path to FDA</a>](https://www.fiercebiotech.com/biotech/bridgebio-aces-phase-3-rare-disease-test-clearing-path-fda)**  
  _Oct 27, 2025 4:09am_  
  BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA approval.

- **[<a href="https://www.fiercebiotech.com/biotech/maplight-goes-public-250m-ipo-fund-cobenfy-competitor" hreflang="en">MapLight goes public via $250M IPO to fund Cobenfy competitor</a>](https://www.fiercebiotech.com/biotech/maplight-goes-public-250m-ipo-fund-cobenfy-competitor)**  
  _Oct 27, 2025 5:34am_  
  MapLight Therapeutics is heading to the Nasdaq this morning via a $250 million IPO the biotech will use to advance its challenger to Bristol Myers Squibb’s schizophrenia med Cobenfy.

- **[<a href="https://www.fiercebiotech.com/biotech/gsk-pens-357m-pact-french-biotech-preclinical-prostate-cancer-adc" hreflang="en">GSK pens $357M pact with French biotech for preclinical prostate cancer ADC</a>](https://www.fiercebiotech.com/biotech/gsk-pens-357m-pact-french-biotech-preclinical-prostate-cancer-adc)**  
  _Oct 27, 2025 4:08am_  
  Fresh from a European cancer conference that was all about antibody-drug conjugates, GSK has turned to French biotech Syndivia for a preclinical prostate cancer prospect.

- **[<a href="https://www.fiercebiotech.com/biotech/novartis-goes-big-neuroscience-12b-deal-late-stage-dystrophy-biotech-avidity" hreflang="en">Novartis goes big for neuroscience with $12B deal for late-stage dystrophy biotech Avidity</a>](https://www.fiercebiotech.com/biotech/novartis-goes-big-neuroscience-12b-deal-late-stage-dystrophy-biotech-avidity)**  
  _Oct 26, 2025 4:02pm_  
  Almost a year after buying Kate Therapeutics, Novartis has scooped up another San Diego-based muscle dystrophy biotech in one of the biggest acquisitions of 2025 so far.


## MHRA – News

- **[Research: Report of The Commission on Human Medicines Isotretinoin Implementation Advisory Expert Working Group](https://www.gov.uk/government/publications/report-of-the-commission-on-human-medicines-isotretinoin-implementation-advisory-expert-working-group)**  
  _2025-10-27T11:00:00Z_  
  Report of Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan.


## arXiv q-bio

- **[Rethinking the Simulation vs. Rendering Dichotomy: No Free Lunch in Spatial World Modelling](https://arxiv.org/abs/2510.20835)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20835v1 Announce Type: new 
Abstract: Spatial world models, representations that support flexible reasoning about spatial relations, are central to developing computational models that could operate in the physical world, but their precise mechanistic underpinnings are nuanced by the borrowing of underspeci…

- **[Consciousness, natural and artificial: an evolutionary advantage for reasoning on reactive substrates](https://arxiv.org/abs/2510.20839)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20839v1 Announce Type: new 
Abstract: Precisely defining consciousness and identifying the mechanisms that effect it is a long-standing question, particularly relevant with advances in artificial intelligence. The scientific community is divided between physicalism and natural dualism. Physicalism posits co…

- **[GEPOC ABM, Generic Population Concept -- Agent-Based Model, Version 2.2](https://arxiv.org/abs/2510.20840)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20840v1 Announce Type: new 
Abstract: The Generic Population Concept - Agent-Based Model, henceforth short, GEPOC ABM, is one of the models within GEPOC, a generic concept to model a country's population and its dynamics using causal modelling approaches. The model is well established and had already proven…

- **[This EEG Looks Like These EEGs: Interpretable Interictal Epileptiform Discharge Detection With ProtoEEG-kNN](https://arxiv.org/abs/2510.20846)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20846v1 Announce Type: new 
Abstract: The presence of interictal epileptiform discharges (IEDs) in electroencephalogram (EEG) recordings is a critical biomarker of epilepsy. Even trained neurologists find detecting IEDs difficult, leading many practitioners to turn to machine learning for help. While existi…

- **[Integrated representational signatures strengthen specificity in brains and models](https://arxiv.org/abs/2510.20847)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20847v1 Announce Type: new 
Abstract: The extent to which different neural or artificial neural networks (models) rely on equivalent representations to support similar tasks remains a central question in neuroscience and machine learning. Prior work has typically compared systems using a single representati…

- **[Multi-stable oscillations in cortical networks with two classes of inhibition](https://arxiv.org/abs/2510.20848)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20848v1 Announce Type: new 
Abstract: In the classic view of cortical rhythms, the interaction between excitatory pyramidal neurons (E) and inhibitory parvalbumin neurons (I) has been shown to be sufficient to generate gamma and beta band rhythms. However, it is now clear that there are multiple inhibitory…

- **[Combinations of histone deacetylase inhibitors extend chronological lifespan in S. cerevisiae](https://arxiv.org/abs/2510.20851)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20851v1 Announce Type: new 
Abstract: Aging is the primary risk factor for nearly all forms of human death, yet pharmaceutical interventions hold the potential to prevent it. Combinations of drugs have been shown to increase the lifespan of model organisms more than individual drugs, and geroprotective hist…

- **[BrainCognizer: Brain Decoding with Human Visual Cognition Simulation for fMRI-to-Image Reconstruction](https://arxiv.org/abs/2510.20855)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20855v1 Announce Type: new 
Abstract: Brain decoding is a key neuroscience field that reconstructs the visual stimuli from brain activity with fMRI, which helps illuminate how the brain represents the world. fMRI-to-image reconstruction has achieved impressive progress by leveraging diffusion models. Howeve…

- **[Vision-language models learn the geometry of human perceptual space](https://arxiv.org/abs/2510.20859)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20859v1 Announce Type: new 
Abstract: In cognitive science and AI, a longstanding question is whether machines learn representations that align with those of the human mind. While current models show promise, it remains an open question whether this alignment is superficial or reflects a deeper corresponden…

- **[Ultra-wideband radar to measure in vivo musculoskeletal forces](https://arxiv.org/abs/2510.20866)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20866v1 Announce Type: new 
Abstract: Accurate measures of musculoskeletal forces are critical for clinicians, biomechanists, and engineers, yet direct measurement is highly invasive and current estimation methods remain limited in accuracy. Here, we demonstrate the application of ultra-wideband radar to no…

- **[Scalable inference of functional neural connectivity at submillisecond timescales](https://arxiv.org/abs/2510.20966)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20966v1 Announce Type: new 
Abstract: The Poisson Generalized Linear Model (GLM) is a foundational tool for analyzing neural spike train data. However, standard implementations rely on discretizing spike times into binned count data, limiting temporal resolution and scalability. Here, we develop Monte Carlo…

- **[In Silico Mapping of Visual Categorical Selectivity Across the Whole Brain](https://arxiv.org/abs/2510.21142)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21142v1 Announce Type: new 
Abstract: A fine-grained account of functional selectivity in the cortex is essential for understanding how visual information is processed and represented in the brain. Classical studies using designed experiments have identified multiple category-selective regions; however, the…

- **[RiboPO: Preference Optimization for Structure- and Stability-Aware RNA Design](https://arxiv.org/abs/2510.21161)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21161v1 Announce Type: new 
Abstract: Designing RNA sequences that reliably adopt specified three-dimensional structures while maintaining thermodynamic stability remains challenging for synthetic biology and therapeutics. Current inverse folding approaches optimize for sequence recovery or single structura…

- **[EEG Dynamic Microstate Patterns Induced by Pulsed Wave Transcranial Photobiomodulation Therapy](https://arxiv.org/abs/2510.21265)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21265v1 Announce Type: new 
Abstract: Transcranial photobiomodulation (tPBM) therapy is an emerging, non-invasive neuromodulation technique that has demonstrated considerable potential in the field of neuropsychiatric disorders. Several studies have found that pulsed wave (PW) tPBM therapy yields superior b…

- **[eMZed 3: flexible and interactive development of scalable LC-MS/MS data analysis workflows in Python](https://arxiv.org/abs/2510.21484)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21484v1 Announce Type: new 
Abstract: Liquid chromatography-mass spectrometry (LC-MS/MS) data analysis requires adaptable software solutions to meet diverse analytical needs. We present eMZed 3, a modern Python framework for flexible and interactive analysis of LC-MS/MS data. eMZed 3 enables users to develo…

- **[Vesicle Translocation into Closed Constrictions as a Function of Molecular Motor Parameters](https://arxiv.org/abs/2510.21567)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21567v1 Announce Type: new 
Abstract: We study the dynamics of molecular motor-driven transport into dendritic spines, which are bulbous intracellular compartments in neurons that play a key role in transmitting signals between neurons. We further develop a stochastic model of vesicle transport in [Park, Si…

- **[Contribution of task-irrelevant stimuli to drift of neural representations](https://arxiv.org/abs/2510.21588)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21588v1 Announce Type: new 
Abstract: Biological and artificial learners are inherently exposed to a stream of data and experience throughout their lifetimes and must constantly adapt to, learn from, or selectively ignore the ongoing input. Recent findings reveal that, even when the performance remains stab…

- **[NeuroPilot: A Realtime Brain-Computer Interface system to enhance concentration of students in online learning](https://arxiv.org/abs/2510.20958)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.20958v1 Announce Type: cross 
Abstract: Prevalence of online learning poses a vital challenge in real-time monitoring of students' concentration. Traditional methods such as questionnaire assessments require manual interventions and webcam-based monitoring fails to provide accurate insights into learners' m…

- **[Spatially inhomogeneous two-cycles in an integrodifference equation](https://arxiv.org/abs/2510.21134)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21134v1 Announce Type: cross 
Abstract: In this work, we prove the existence of a 2-cycle in an integrodifference equation with a Laplace kernel and logistic growth function, connecting two non-trivial fixed points of the second iterate of the logistic map in the non-chaotic regime. This model was first stu…

- **[WhaleVAD-BPN: Improving Baleen Whale Call Detection with Boundary Proposal Networks and Post-processing Optimisation](https://arxiv.org/abs/2510.21280)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21280v1 Announce Type: cross 
Abstract: While recent sound event detection (SED) systems can identify baleen whale calls in marine audio, challenges related to false positive and minority-class detection persist. We propose the boundary proposal network (BPN), which extends an existing lightweight SED syste…

- **[REVE: A Foundation Model for EEG -- Adapting to Any Setup with Large-Scale Pretraining on 25,000 Subjects](https://arxiv.org/abs/2510.21585)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21585v1 Announce Type: cross 
Abstract: Foundation models have transformed AI by reducing reliance on task-specific data through large-scale pretraining. While successful in language and vision, their adoption in EEG has lagged due to the heterogeneity of public datasets, which are collected under varying p…

- **[Foundation Models in Dermatopathology: Skin Tissue Classification](https://arxiv.org/abs/2510.21664)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.21664v1 Announce Type: cross 
Abstract: The rapid generation of whole-slide images (WSIs) in dermatopathology necessitates automated methods for efficient processing and accurate classification. This study evaluates the performance of two foundation models, UNI and Virchow2, as feature extractors for classi…

- **[Slow Transition to Low-Dimensional Chaos in Heavy-Tailed Recurrent Neural Networks](https://arxiv.org/abs/2505.09816)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2505.09816v2 Announce Type: replace 
Abstract: Growing evidence suggests that synaptic weights in the brain follow heavy-tailed distributions, yet most theoretical analyses of recurrent neural networks (RNNs) assume Gaussian connectivity. We systematically study the activity of RNNs with random weights drawn fro…

- **[BioCube: A Multimodal Dataset for Biodiversity Research](https://arxiv.org/abs/2505.11568)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2505.11568v3 Announce Type: replace 
Abstract: Biodiversity research requires complete and detailed information to study ecosystem dynamics at different scales. Employing data-driven methods like Machine Learning is getting traction in ecology and more specific biodiversity, offering alternative modelling pathwa…

- **[Intrinsic Goals for Autonomous Agents: Model-Based Exploration in Virtual Zebrafish Predicts Ethological Behavior and Whole-Brain Dynamics](https://arxiv.org/abs/2506.00138)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2506.00138v2 Announce Type: replace 
Abstract: Autonomy is a hallmark of animal intelligence, enabling adaptive and intelligent behavior in complex environments without relying on external reward or task structure. Existing reinforcement learning approaches to exploration in reward-free environments, including a…

- **[Identifying interactions across brain areas while accounting for individual-neuron dynamics with a Transformer-based variational autoencoder](https://arxiv.org/abs/2506.02263)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2506.02263v2 Announce Type: replace 
Abstract: Advances in large-scale recording technologies now enable simultaneous measurements from multiple brain areas, offering new opportunities to study signal transmission across interacting components of neural circuits. However, neural responses exhibit substantial tri…

- **[POCO: Scalable Neural Forecasting through Population Conditioning](https://arxiv.org/abs/2506.14957)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2506.14957v2 Announce Type: replace 
Abstract: Predicting future neural activity is a core challenge in modeling brain dynamics, with applications ranging from scientific investigation to closed-loop neurotechnology. While recent models of population activity emphasize interpretability and behavioral decoding, n…

- **[Domain Knowledge Infused Conditional Generative Models for Accelerating Drug Discovery](https://arxiv.org/abs/2510.09837)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2510.09837v2 Announce Type: replace 
Abstract: The role of Artificial Intelligence (AI) is growing in every stage of drug development. Nevertheless, a major challenge in drug discovery AI remains: Drug pharmacokinetic (PK) and Drug-Target Interaction (DTI) datasets collected in different studies often exhibit li…

- **[Time-Evolving Dynamical System for Learning Latent Representations of Mouse Visual Neural Activity](https://arxiv.org/abs/2408.07908)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2408.07908v3 Announce Type: replace-cross 
Abstract: Seeking high-quality representations with latent variable models (LVMs) to reveal the intrinsic correlation between neural activity and behavior or sensory stimuli has attracted much interest. In the study of the biological visual system, naturalistic visual s…

- **[Brain-like Variational Inference](https://arxiv.org/abs/2410.19315)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2410.19315v3 Announce Type: replace-cross 
Abstract: Inference in both brains and machines can be formalized by optimizing a shared objective: maximizing the evidence lower bound (ELBO) in machine learning, or minimizing variational free energy (F) in neuroscience (ELBO = -F). While this equivalence suggests a u…

- **[Language Models Are Capable of Metacognitive Monitoring and Control of Their Internal Activations](https://arxiv.org/abs/2505.13763)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2505.13763v2 Announce Type: replace-cross 
Abstract: Large language models (LLMs) can sometimes report the strategies they actually use to solve tasks, yet at other times seem unable to recognize those strategies that govern their behavior. This suggests a limited degree of metacognition - the capacity to monito…

- **[A robust and versatile deep learning model for prediction of the arterial input function in dynamic small animal $\left[^{18}\text{F}\right]$FDG PET imaging](https://arxiv.org/abs/2507.02367)**  
  _Mon, 27 Oct 2025 00:00:00 -0400_  
  arXiv:2507.02367v2 Announce Type: replace-cross 
Abstract: Dynamic positron emission tomography (PET) and kinetic modeling are pivotal in advancing tracer development research in small animal studies. Accurate kinetic modeling requires precise input function estimation, traditionally achieved via arterial blood sampli…
